glutathione mutations in sclc patients Increased antioxidative defense and reduced advanced glycation end-product formation by metabolic adaptation non-small-cell-lung-cancer Cell Death, Molecular Targeted Therapies,
Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming in EGFR Mutant Lung Cancer Frontiers Molecular subtypes based on ferroptosis related genes and tumor microenvironment infiltration characterization in small cell lung cancer Cellular Compartmentalization, Glutathione Transport and Its Relevance in Some Pathologies Frontiers Metabolic reprogramming in lung cancer and its clinical implication In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Science Advances
Pay in 4 interest-free payments of $6.97 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




